Abstract
Background: Graves’ disease (GD) is the most common cause of hyperthyroidism in children and adolescents. Treatments consist of medication, radioactive iodine (RAI) therapy and surgery. Currently, radioactive iodine therapy is the first line treatment in many medical centers.
Objective: To evaluate the effectiveness and safety of RAI therapy in childhood GD.
Material and Method: A retrospective study was performed in 46 GD patients, aged at onset <15 years, who had undergone RAI therapy at the age >10 years. Goiter grading, evidence of hypothyroidism, severity of ophthalmopathy, RAI dosage and side effects of RAI therapy were evaluated.
Results: The cure rate was 95.6%. All participating patients had goiter reduction (p = 0.005). Hypothyroidism was induced in 33 (71.7%) and 11 (23.9%) patients after the first and second RAI therapy. The total RAI dosage was significantly higher in the patients with failure response (p = 0.001). The average time to induce hypothyroidism after the first RAI therapy was 127.5 (IQR: 94.5-223.0) days. All of the patients had improvement of ophthalmopathy and none had thyroid carcinoma during the follow-up period of 42.5 (IQR: 17-52) months.
Conclusion: Radioactive iodine therapy is effective and safe in the treatment of children and adolescents with Graves’ disease.
| Original language | English |
|---|---|
| Pages (from-to) | S112-S119 |
| Journal | Journal of the Medical Association of Thailand |
| Volume | 99 |
| Publication status | Published - 1 Aug 2016 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Effectiveness and Safety of Radioactive Iodine Therapy in Childhood Graves’ Disease in Khon Kaen, Thailand'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver